By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mike Stratton has been named the new director of the Wellcome Trust Sanger Institute, where he has served as deputy director since 2007.

Stratton has been acting director of the institute's Board of Management since March, when Allan Bradley stepped down as director after 10 years at the institute's helm in order to found a startup company and focus on his research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.